SAN FRANCISCO, Dec. 20, 2017 /PRNewswire/ -- Invitae Corporation
(NYSE: NVTA), one of the fastest growing genetic information
companies, today announced that Sean
George, chief executive officer of Invitae, will present at
the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at 2:00 p.m. Pacific at The Westin St. Francis in
San Francisco.
The live webcast of the presentation may be accessed by visiting
the investors section of the company's website at ir.invitae.com. A
replay of the webcast will be available shortly after the
conclusion of the presentation and will be archived on the
company's website.
About Invitae
Invitae Corporation's (NYSE: NVTA)
mission is to bring comprehensive genetic information into
mainstream medical practice to improve the quality of healthcare
for billions of people. Specializing in genetic diagnostics in
clinical areas across all stages of life, Invitae is aggregating
the world's genetic tests into a single service with better
quality, faster turnaround time, and lower prices. The company
provides a variety of diagnostic tests with clinical utility in
preimplantation and carrier screening for inherited disorders,
miscarriage analysis, pediatric and developmental disorders,
neurological disorders, cardiovascular disorders, metabolic
disorders, and hereditary cancers. For more information, visit our
website at invitae.com.
Contact:
Kate McNeil
ir@invitae.com
347-204-4226
View original content with
multimedia:http://www.prnewswire.com/news-releases/invitae-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300573711.html
SOURCE Invitae Corporation